Brief: Aspira Women's Health Names Torsten Hombeck As Chief Financial Officer
16/05/2023 21:52
Akari Therapeutics PLC AKTX.O :
* ASPIRA WOMEN'S HEALTH NAMES TORSTEN HOMBECK AS CHIEF
FINANCIAL
OFFICER
Source text for Eikon: ID:nGNX3c6m3M
Further company coverage: AKTX.O
Recent news on Akari Therapeutics
See all newsBrief: Akari Therapeutics - Aktx-101 Demonstrates Robust Anti-Tumor Activity In Urothelial Cancer Preclinical Models
UK's Akari Therapeutics Q2 net loss widens on higher R&D for AKTX-101
Akari Therapeutics PLC reports results for the quarter ended June 30 - Earnings Summary
Akari Therapeutics PLC expected to post a loss of $1.40 a share - Earnings Preview
Brief: Akari Therapeutics Enters Strategic Research Collaboration With Whitehawk Therapeutics